What would be your dream come true for healthcare in 2019?
For Crossix’s Sarah Caldwell, it all starts with data. Hear more predictions and trends for the coming year in this first edition of MM&M’s sponsored series, Outlook 2019.
News
Caris Life Sciences names Srikant Ramaswami chief communications officer
Ramaswami was most recently at rbb Communications and spent much of his career in pharma, including roles at J&J, Pfizer, and Merck.
Study: Marketing opioids to doctors tied to increased overdose deaths
Researchers looked at the connections between the amount of marketing to doctors and opioid overdose deaths in a study published in JAMA.
Five things for pharma marketers to know: Friday, January 18, 2019
Lawmakers want to end tax exemption for pharma ads; Gottlieb warns of “hard decisions” at FDA if shutdown continues; Feds to allow drugmakers to develop over-the-counter naloxone.
Bill to end tax exemption for pharma marketing introduced in Senate
Sixteen Democratic senators are backing the latest version of a bill to end the exemption for DTC advertising.
Five things for pharma marketers to know: Thursday, January 17, 2019
Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
Kaiser Permanente launches united Permanente Medicine brand
The branding change unifies the eight regional physician groups of the Permanente Medical Group.
GCI Health to open Singapore office, its first in Asia
It’s the first step in a planned regional expansion for GCI.
Five things for pharma marketers to know: Wednesday, January 16, 2019
Court documents detail aggressive marketing of OxyContin; Walgreens partners with Microsoft on research; Allergan wants High Court to take up Restasis patent lawsuit.
Five things for pharma marketers to know: Tuesday, January 15, 2019
Walmart pharmacies set to leave CVS network; Edwards Lifesciences settles patent dispute with Boston Scientific; Pfizer to cut 150 R&D jobs.
Want to read more?
Please login or register first to view this content.
